Prudential Financial Inc Black Diamond Therapeutics, Inc. Transaction History

Prudential Financial Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$22.23 - $34.75 $833,402 - $1.3 Million	-37,490 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$29.47 - $35.0 $481,834 - $572,250	16,350 Added 77.34%	37,490 $1.2 Million
Q3 2020 Nov 16, 2020	BUY	$26.17 - $43.07 $4,710 - $7,752	180 Added 0.86%	21,140 $639,000
Q2 2020 Aug 12, 2020	BUY	$22.3 - $44.8 $1,115 - $2,240	50 Added 0.24%	20,960 $883,000
Q1 2020 May 12, 2020	BUY	$18.18 - $39.48 $380,143 - $825,526	20,910 New	20,910 $521,000

117

48.8M

1.84M

1.93M

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $70.1M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.